Us Apheresis Service Market Market Overview
Us Apheresis Service Market Market Size Was Valued At USD 760.91 Million In 2024. The Us Apheresis Service Market Research Report Industry Is Projected To Grow From USD 812.50 Million In 2025 To USD 1,832.77 Million By 2035, Exhibiting A Compound Annual Growth Rate (CAGR) Of 8.47% During The Forecast Period (2024 – 2035).
Increasing Prevalence Of Chronic Diseases, Rising Demand For Plasma-Derived Therapies And Favorable Reimbursement Policies is driving the Us Apheresis Service Market Market.
As per Analyst at MRFR,” The increasing prevalence of chronic diseases, rising demand for plasma-derived therapies, and favorable reimbursement policies are fueling the growth of the US Apheresis Market. Additionally, high procedure costs, safety concerns in blood transfusions, and the recruitment of voluntary non-remunerated donors are restraining factors for the market. However, the increasing demand for platelet-rich plasma therapy and apheresis for leukemia and pediatric patients will provide growth opportunities for the market in the future”
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Us Apheresis Service Market Market Trends
INCREASING DEMAND FOR PLATELET-RICH PLASMA THERAPY
Platelet-rich plasma (PRP) therapy has garnered significant attention in recent years, particularly within the fields of orthopedics, dermatology, and sports medicine. The therapy involves using a patient’s own platelets, which are concentrated from their blood, to accelerate healing and tissue regeneration. However, the growing demand for PRP therapy has also led to an increased need for apheresis services, as this technique is often employed to collect platelets from healthy blood donors for PRP treatments. Apheresis allows for the efficient extraction of platelets, which are then used in PRP therapy to treat a variety of conditions such as musculoskeletal injuries, hair loss, and even skin rejuvenation.
In orthopedics, PRP therapy is commonly used to treat tendon injuries, ligament sprains, and osteoarthritis by promoting tissue healing and reducing inflammation. In dermatology, it has gained popularity for its ability to stimulate hair growth in patients with androgenic alopecia (male or female pattern baldness) and improve the appearance of the skin by reducing wrinkles and promoting collagen production. As the clinical applications of PRP therapy expand and its regenerative properties are increasingly recognized, more healthcare providers are incorporating them into treatment regimens. This shift is creating substantial demand for platelet collections, which in turn, is fueling the need for apheresis services.
Us Apheresis Service Market Market Segment Insights
Us Apheresis Service Market Research Report service type Insights
Based on service type, the US Apheresis Service Market has been segmented into Donor/Automated Apheresis, Therapeutic Apheresis, and Stem Cell Collection and Processing. The Therapeutic Apheresis segment held the largest market share in 2024, and the Stem Cell Collection and Processing segment is the fastest-growing segment during the forecast period (2025 -2035).
The U.S. Apheresis Service Market, segmented by service type, includes Donor/Automated Apheresis, Therapeutic Apheresis, and Stem Cell Collection and Processing. In 2024, Therapeutic Apheresis dominated the market share, driven by its critical role in treating autoimmune and neurological disorders, as well as its increasing adoption in hospitals and specialty clinics. This segment's growth is further supported by rising prevalence of chronic diseases and advancements in apheresis technology.
However, the fastest-growing segment over the forecast period (2025–2035) is expected to be Stem Cell Collection and Processing. This growth is attributed to increasing applications in regenerative medicine, rising demand for stem cell transplantation, and ongoing research in cell-based therapies. The segment is also benefitting from expanding clinical trials and growing awareness about stem cell banking. These trends highlight a dynamic shift in the market, with innovation and personalized medicine driving future demand.
Figure 1: Us Apheresis Service Market Market, By service type, 2024 & 2035 (USD Million)
Us Apheresis Service Market Research Report By Application Insights
Based on Application, the US Apheresis Service Market has been segmented into Neurological Disorders, Autoimmune Disorders, Hematologic Disorders, Oncology, Metabolic Toxicology Disorders, Infectious Diseases, Cardiovascular Disorders, and Others. The Hematologic Disorders segment held the largest market in 2024, and the Oncology segment is the fastest growing segment during the forecast period.
The U.S. Apheresis Service Market, based on application, is segmented into Neurological Disorders, Autoimmune Disorders, Hematologic Disorders, Oncology, Metabolic Toxicology Disorders, Infectious Diseases, Cardiovascular Disorders, and Others. In 2024, the Hematologic Disorders segment held the largest market share due to the high prevalence of blood-related conditions such as leukemia, lymphoma, and sickle cell disease that require apheresis as part of their treatment.
The demand is also driven by increasing awareness and advancements in transfusion medicine. However, the Oncology segment is projected to be the fastest-growing during the 2025–2035 forecast period. This growth is fueled by the rising incidence of cancer, growing use of apheresis in cell therapy and immunotherapy, and expanding clinical research in oncology-focused treatments. The market dynamics reflect a growing reliance on apheresis as a supportive and therapeutic tool in both chronic and life-threatening disease management.
Us Apheresis Service Market Research Report End User Insights
Based on End User, the US Apheresis Service Market has been segmented into Hospitals, Blood Banks, Specialty Clinics, Research Laboratories, and Biotechnology Pharmaceutical Companies. The Blood Banks segment held the largest market in 2024 and the Research Laboratories segment is the fastest growing segment during the forecast period.
The U.S. Apheresis Service Market, segmented by end user, includes Hospitals, Blood Banks, Specialty Clinics, Research Laboratories, and Biotechnology Pharmaceutical Companies. In 2024, the Blood Banks segment accounted for the largest market share due to the high demand for blood component separation, donor apheresis procedures, and the growing need for safe and efficient blood supply management. Blood banks play a critical role in meeting the needs of patients requiring plasma, platelets, and other blood components.
However, the Research Laboratories segment is projected to witness the fastest growth during the forecast period (2025–2035). This is driven by increased investments in biomedical research, advancements in cell therapy and gene therapy, and the growing use of apheresis in experimental treatments and clinical trials. The expanding focus on personalized medicine and innovation in therapeutic approaches is expected to accelerate demand for apheresis services within research environments.
Us Apheresis Service Market Research Report Region Insights
Based on region, the US Apheresis Service Market has been segmented into North, South, Midwest, and West. South accounted for the largest market share in 2024 and is anticipated to reach USD 757.67 million by 2035 and projected to grow at the highest CAGR of 9.63% during the forecast period.
The U.S. Apheresis Service Market, based on region, is segmented into North, South, Midwest, and West. In 2024, the South region held the largest market share and is expected to maintain its dominance through 2035. The market in the South is projected to reach USD 757.67 million by 2035, growing at the highest compound annual growth rate (CAGR) of 9.63% during the forecast period. This growth is driven by a high concentration of healthcare facilities, rising prevalence of chronic diseases, increasing adoption of advanced apheresis technologies, and supportive state-level healthcare initiatives.
Additionally, the presence of major blood banks and research institutions further boosts demand for apheresis services in the region. The South’s growing population and expanding access to specialized treatments also contribute to its leading position and rapid market expansion within the U.S. apheresis services landscape.
Figure 2: Us Apheresis Service Market Market, by Region, 2024 & 2035 (USD Million)
Us Apheresis Service Market Research Report Key Market Players & Competitive Insight
Many global, Region, and local vendors characterize the Peptides Market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality products to survive and succeed in an intensely competitive market.
The major players in the market include VERSITI, Fresenius Medical Care Ag, VITALANT, Carter BLOODCARE, IMPACTLIFE, Mayo Foundation For Medical Education And Research (MFMER), New York Blood Center (NYBC), The American National Red Cross, BIOBRIDGE Global, San Diego Blood Bank And Among Others. The Us Apheresis Service Market Market is a consolidated market due to increasing competition, acquisitions, mergers and other strategic market developments and decisions to improve operational effectiveness.
Key Companies in the Us Apheresis Service Market Market include.
- VERSITI
- Fresenius Medical Care Ag
- VITALANT
- Carter BLOODCARE
- IMPACTLIFE
- Mayo Foundation For Medical Education And Research (MFMER)
- New York Blood Center (NYBC)
- The American National Red Cross
- BIOBRIDGE Global
- San Diego Blood Bank
Us Apheresis Service Market Market Segmentation
Us Apheresis Service Market Market by Service Type Outlook (USD Million, 2019-2035)
- Donor/Automated Apheresis
- Therapeutic Apheresis
- Plasma Exchange
- Red Blood Cell Exchange
- Extracorporeal Photopheresis
- Leukocytapheresis
- Thrombocytapheresis
- Erythrocytapheresis
- Therapeutic Phlebotomy
- Stem Cell Collection and Processing
Us Apheresis Service Market Market by Application Outlook (USD Million, 2019-2035)
- Neurological Disorders
- Autoimmune Disorders
- Hematologic Disorders
- Oncology
- Metabolic Toxicology Disorders
- Infectious Diseases
- Cardiovascular Disorders
- Others
Us Apheresis Service Market Market by End User ( USD Million, 2019-2035)
- Hospitals
- Blood Banks
- Specialty Clinics
- Research Laboratories
- Biotechnology Pharmaceutical Companies
Us Apheresis Service Market Research Report Region Outlook
- US
- North
- South
- Midwest
- West
|
Report Attribute/Metric
|
Details
|
|
Market Size 2024
|
USD 760.91 Million
|
|
Market Size 2025
|
USD 812.50 Million
|
|
Market Size 2035
|
USD 1,832.77 Million
|
|
Compound Annual Growth Rate (CAGR)
|
8.47% (2024-2035)
|
|
Base Year
|
2024
|
|
Market Forecast Period
|
2025-2035
|
|
Historical Data
|
2019- 2024
|
|
Market Forecast Units
|
Value (USD Million)
|
|
Report Coverage
|
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
|
|
Segments Covered
|
By Service Type, By Application, By End User and Region.
|
|
Geographies Covered
|
North, South, Midwest, and West.
|
|
Countries Covered
|
North, South, Midwest, and West.
|
|
Key Companies Profiled
|
VERSITI, Fresenius Medical Care Ag, VITALANT, Carter BLOODCARE, IMPACTLIFE, Mayo Foundation For Medical Education And Research (MFMER), New York Blood Center (NYBC), The American National Red Cross, BIOBRIDGE Global, San Diego Blood Bank And Among Others.
|
|
Key Market Opportunities
|
· Increasing Demand For Platelet-Rich Plasma Therapy
· Apheresis For Leukemia And Pediatric Patients
|
|
Key Market Dynamics
|
· Increasing Prevalence Of Chronic Diseases
· Rising Demand For Plasma-Derived Therapies
|
Frequently Asked Questions (FAQ) :
The Us Apheresis Service Market Market size is expected to be valued at USD 1,832.77 Million in 2035.
The global market is projected to grow at a CAGR of 8.47% during the forecast period, 2024-2035.
South had the largest share of the global market.
The key players in the market are Astec Industries VERSITI, Fresenius Medical Care Ag, VITALANT, Carter BLOODCARE, IMPACTLIFE, Mayo Foundation For Medical Education And Research (MFMER), New York Blood Center (NYBC), The American National Red Cross, BIOBRIDGE Global, San Diego Blood Bank And Among Others.
Thin-film Extraction dominated the market in 2024.
Cellulosic segment had the largest revenue share of the global market.
